Passage Bio Stock Technical Analysis
| PASG Stock | USD 8.73 0.12 1.39% |
As of the 23rd of February, Passage Bio holds the Coefficient Of Variation of 3238.75, risk adjusted performance of 0.033, and Semi Deviation of 6.58. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Passage Bio, as well as the relationship between them. Please check Passage Bio information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if Passage Bio is priced some-what accurately, providing market reflects its current price of 8.73 per share. Given that Passage Bio has jensen alpha of (0.01), we recommend you to check out Passage Bio's recent market performance to make sure the company can sustain itself at a future point.
Passage Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Passage, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PassagePassage Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Passage Bio Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 39.6 | Strong Buy | 5 | Odds |
Most Passage analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Passage stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Passage Bio, talking to its executives and customers, or listening to Passage conference calls.
Can Biotechnology industry sustain growth momentum? Does Passage have expansion opportunities? Factors like these will boost the valuation of Passage Bio. Anticipated expansion of Passage directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Passage Bio demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Investors evaluate Passage Bio using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Passage Bio's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Passage Bio's market price to deviate significantly from intrinsic value.
It's important to distinguish between Passage Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Passage Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Passage Bio's market price signifies the transaction level at which participants voluntarily complete trades.
Passage Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Passage Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Passage Bio.
| 11/25/2025 |
| 02/23/2026 |
If you would invest 0.00 in Passage Bio on November 25, 2025 and sell it all today you would earn a total of 0.00 from holding Passage Bio or generate 0.0% return on investment in Passage Bio over 90 days. Passage Bio is related to or competes with NuCana PLC, MetaVia, Lisata Therapeutics, Allarity Therapeutics, CytoMed Therapeutics, Enlivex Therapeutics, and Cingulate. Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases More
Passage Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Passage Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Passage Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.02 | |||
| Information Ratio | 0.0215 | |||
| Maximum Drawdown | 58.13 | |||
| Value At Risk | (9.87) | |||
| Potential Upside | 10.28 |
Passage Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Passage Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Passage Bio's standard deviation. In reality, there are many statistical measures that can use Passage Bio historical prices to predict the future Passage Bio's volatility.| Risk Adjusted Performance | 0.033 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0238 | |||
| Treynor Ratio | 0.0603 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Passage Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Passage Bio February 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.033 | |||
| Market Risk Adjusted Performance | 0.0703 | |||
| Mean Deviation | 5.3 | |||
| Semi Deviation | 6.58 | |||
| Downside Deviation | 7.02 | |||
| Coefficient Of Variation | 3238.75 | |||
| Standard Deviation | 7.79 | |||
| Variance | 60.61 | |||
| Information Ratio | 0.0215 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0238 | |||
| Treynor Ratio | 0.0603 | |||
| Maximum Drawdown | 58.13 | |||
| Value At Risk | (9.87) | |||
| Potential Upside | 10.28 | |||
| Downside Variance | 49.32 | |||
| Semi Variance | 43.27 | |||
| Expected Short fall | (5.37) | |||
| Skewness | 1.44 | |||
| Kurtosis | 7.69 |
Passage Bio Backtested Returns
Passage Bio appears to be slightly risky, given 3 months investment horizon. Passage Bio maintains Sharpe Ratio (i.e., Efficiency) of 0.0305, which implies the firm had a 0.0305 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Passage Bio, which you can use to evaluate the volatility of the company. Please evaluate Passage Bio's Semi Deviation of 6.58, risk adjusted performance of 0.033, and Coefficient Of Variation of 3238.75 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Passage Bio holds a performance score of 2. The company holds a Beta of 3.82, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Passage Bio will likely underperform. Please check Passage Bio's expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether Passage Bio's historical price patterns will revert.
Auto-correlation | -0.56 |
Good reverse predictability
Passage Bio has good reverse predictability. Overlapping area represents the amount of predictability between Passage Bio time series from 25th of November 2025 to 9th of January 2026 and 9th of January 2026 to 23rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Passage Bio price movement. The serial correlation of -0.56 indicates that roughly 56.0% of current Passage Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.56 | |
| Spearman Rank Test | -0.86 | |
| Residual Average | 0.0 | |
| Price Variance | 7.65 |
Passage Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Passage Bio Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Normalized Average True Range is used to analyze tradable apportunities for Passage Bio across different markets.
About Passage Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Passage Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Passage Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Passage Bio price pattern first instead of the macroeconomic environment surrounding Passage Bio. By analyzing Passage Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Passage Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Passage Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
Passage Bio February 23, 2026 Technical Indicators
Most technical analysis of Passage help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Passage from various momentum indicators to cycle indicators. When you analyze Passage charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.033 | |||
| Market Risk Adjusted Performance | 0.0703 | |||
| Mean Deviation | 5.3 | |||
| Semi Deviation | 6.58 | |||
| Downside Deviation | 7.02 | |||
| Coefficient Of Variation | 3238.75 | |||
| Standard Deviation | 7.79 | |||
| Variance | 60.61 | |||
| Information Ratio | 0.0215 | |||
| Jensen Alpha | (0.01) | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0238 | |||
| Treynor Ratio | 0.0603 | |||
| Maximum Drawdown | 58.13 | |||
| Value At Risk | (9.87) | |||
| Potential Upside | 10.28 | |||
| Downside Variance | 49.32 | |||
| Semi Variance | 43.27 | |||
| Expected Short fall | (5.37) | |||
| Skewness | 1.44 | |||
| Kurtosis | 7.69 |
Passage Bio February 23, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Passage stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 542.24 | ||
| Daily Balance Of Power | 0.26 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 8.82 | ||
| Day Typical Price | 8.79 | ||
| Price Action Indicator | (0.03) |
Complementary Tools for Passage Stock analysis
When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |